{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:58:32Z","timestamp":1790693912414,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,5,1]],"date-time":"2027-05-01T00:00:00Z","timestamp":1809129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,5,1]],"date-time":"2027-05-01T00:00:00Z","timestamp":1809129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["27105"],"award-info":[{"award-number":["27105"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2027,5]]},"DOI":"10.1016\/j.vhri.2026.101697","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:10:06Z","timestamp":1787083806000},"page":"101697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mapping Minnesota Living with Heart Failure Questionnaire Onto EQ-5D-5L and SF-6Dv2 in Iranian Patients With Ischemic Heart Failure"],"prefix":"10.1016","volume":"59","author":[{"given":"Mostafa","family":"Habibian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Hadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10440","key":"10.1016\/j.vhri.2026.101697_bib1","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Vollset","year":"2024","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.vhri.2026.101697_bib2","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.vhri.2026.101697_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12963-016-0091-3","article-title":"Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model","volume":"14","author":"Yin","year":"2016","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.vhri.2026.101697_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12955-016-0425-7","article-title":"The Minnesota living with heart failure questionnaire: comparison of different factor structures","volume":"14","author":"Bilbao","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.vhri.2026.101697_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7525-4-20","article-title":"Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease","volume":"4","author":"van Stel","year":"2006","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"10.1016\/j.vhri.2026.101697_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70396","article-title":"Validation study of the Iranian version of Minnesota living with Heart Failure Questionnaire (MLHF-Q): a cross-sectional study","volume":"8","author":"Heravi-Karimooi","year":"2025","journal-title":"Health Sci Rep"},{"issue":"5","key":"10.1016\/j.vhri.2026.101697_bib7","first-page":"559","article-title":"Quality of life in heart failure patients using the Minnesota Living with Heart Failure Questionnaire (MLHF)","volume":"15","author":"Somayeh","year":"2016","journal-title":"Payesh J"},{"issue":"1","key":"10.1016\/j.vhri.2026.101697_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12913-025-12431-3","article-title":"Cost-effectiveness and budget impact analysis of Rivaroxaban with or without aspirin compared to aspirin alone in patients with coronary and peripheral artery diseases in Iran","volume":"25","author":"Goudarzi","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vhri.2026.101697_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1075277","article-title":"A cost-effectiveness analysis of risk-based intervention for prevention of cardiovascular diseases in IraPEN program: a modeling study","volume":"11","author":"Jamshidi","year":"2023","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.vhri.2026.101697_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12962-022-00402-y","article-title":"Cost-effectiveness analysis of fractional flow reserve versus angiography among patients with coronary artery disease undergoing borderline coronary lesions treatment in Iran","volume":"20","author":"Keshavarz","year":"2022","journal-title":"Cost Eff Resour Alloc"},{"issue":"1","key":"10.1016\/j.vhri.2026.101697_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12962-025-00661-5","article-title":"Cost-effectiveness analysis of an implantable cardiac defibrillator compared with pharmaceutical therapy in patients hospitalized with arrhythmia in Iran","volume":"23","author":"Nowruzi","year":"2025","journal-title":"Cost Eff Resour Alloc"},{"issue":"4","key":"10.1016\/j.vhri.2026.101697_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jval.2022.09.2477","article-title":"Mapping studies to estimate health-state utilities from nonpreference-based outcome measures: a systematic review on how repeated measurements are taken into account","volume":"26","author":"Oliveira Gon\u00e7alves","year":"2023","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2026.101697_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1524-4733.2008.00425.x","article-title":"Utility estimates for decision-analytic modeling in chronic heart failure\u2014health states based on New York Heart Association classes and number of rehospitalizations","volume":"12","author":"G\u00f6hler","year":"2009","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2026.101697_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40258-021-00682-0","article-title":"Indirect and direct mapping of the cancer-specific EORTC QLQ-C30 onto EQ-5D-5L utility scores","volume":"20","author":"Meunier","year":"2022","journal-title":"Appl Health Econ Health Policy"},{"issue":"10","key":"10.1016\/j.vhri.2026.101697_bib15","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1007\/s11136-020-02531-4","article-title":"Mapping the Minnesota living with heart failure questionnaire (MLHFQ) onto the assessment of quality of life 8D (AQoL-8D) utility scores","volume":"29","author":"Catchpool","year":"2020","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.vhri.2026.101697_bib16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jval.2017.09.017","article-title":"Development of methods for the mapping of utilities using mixture models: mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in patients with asthma","volume":"21","author":"Gray","year":"2018","journal-title":"Value Health"},{"issue":"25","key":"10.1016\/j.vhri.2026.101697_bib18","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.vhri.2026.101697_bib19","first-page":"204","article-title":"Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention","volume":"22","author":"Sarrafzadegan","year":"2019","journal-title":"Arch Iran Med"},{"issue":"1","key":"10.1016\/j.vhri.2026.101697_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40258-024-00919-8","article-title":"The short Form 6 dimensions (SF-6D): development and evolution","volume":"23","author":"Mukuria","year":"2025","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"10.1016\/j.vhri.2026.101697_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","article-title":"A review of studies mapping (or cross walking) non-preference-based measures of health to generic preference-based measures","volume":"11","author":"Brazier","year":"2010","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.vhri.2026.101697_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jval.2016.11.006","article-title":"Mapping to estimate health-state utility from non\u2013preference-based outcome measures: an ISPOR good practices for outcomes research task force report","volume":"20","author":"Wailoo","year":"2017","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.vhri.2026.101697_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1191\/026921501680425216","article-title":"Psychometric properties of the Minnesota Living With Heart Failure Questionnaire (MLHF-Q)","volume":"15","author":"Middel","year":"2001","journal-title":"Clin Rehabil"},{"issue":"4","key":"10.1016\/j.vhri.2026.101697_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0002-8703(92)90986-6","article-title":"Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group","volume":"124","author":"Rector","year":"1992","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.vhri.2026.101697_bib25","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s11136-024-03649-5","article-title":"Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration","volume":"33","author":"Daroudi","year":"2024","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.vhri.2026.101697_bib26","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s11136-023-03378-1","article-title":"A national survey of Iranian general population to estimate a value set for the EQ-5D-5L","volume":"32","author":"Afshari","year":"2023","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.vhri.2026.101697_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11136-004-1014-5","article-title":"The Short Form Health Survey (SF-36): translation and validation study of the Iranian version","volume":"14","author":"Montazeri","year":"2005","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.vhri.2026.101697_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12955-020-01368-2","article-title":"Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure","volume":"18","author":"Kularatna","year":"2020","journal-title":"Health Qual Life Outcomes"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:02:05Z","timestamp":1790690525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,5]]},"references-count":27,"alternative-id":["S2212109926001123"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101697","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2027,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping Minnesota Living with Heart Failure Questionnaire Onto EQ-5D-5L and SF-6Dv2 in Iranian Patients With Ischemic Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101697"}}